I've got offers from both platforms. The GS opportunity is within thier WRA group in SF (across multiple industries but 50% of workflow is HC) and Barcap is within their HC group in NYC. I have 3yrs of HC experience prior to this and have an interest in the field.
Both have great cultures and represent unique opportunities. Any thoughts about two groups? Experiences, etc?
Thanks.
| +151 | How are women treated in IB? | 75 | 13m | |
| +117 | A Guide to HK Investment Banking - 10 Most Frequently Asked Questions (2024) | 31 | 13m | |
| +83 | College Transitions updated 2024 IB ranking | 36 | 24m | |
| +65 | How to Not Feel Anxious About SA Internship | 24 | 2d | |
| +27 | CVP diversity quotas increased? | 6 | 1s | |
| +26 | UBS = U Be Shite in Americas? | 4 | 2d | |
| +24 | EB Return Offer Rates | 20 | 16h | |
| +23 | MS & GS vs JPM | 14 | 7h | |
| +22 | May 2024 Grad - Big 4 Audit or T1 MSF? | 15 | 1d | |
| +21 | 2 Offers! Need Advice | 17 | 3d |
Career Resources
Get instant access to lessons taught by experienced private equity pros and bulge bracket investment bankers including financial statement modeling, DCF, M&A, LBO, Comps and Excel Modeling.
Have you read all the news of potential changes at Barclays? Lots of big names have left, and the Brits don't seem interested in growing Barclays with an I-bank division.
Just something to consider. I also presume the GS name would never hurt if you decide to change your path later on.
http://www.bloomberg.com/news/2014-06-03/barclays-said-to-start-cutting…
As I understand it. The cuts are in fixed income and they plan to continue to focus on their coverage efforts. I do agree there is some headline risk.
GS certainly has the brand and strengths in M&A but wanted to see if anyone had experience with that group.
The cuts at Barclays are coming from non-core business lines, not traditional coverage and product investment banking groups. In fact, a good deal of the money saved from these cuts will be reinvested into the traditional investment banking division.
considering that several group heads have left in IB at Barcap, it's not a good sign. However I don't think it'll matter too much for you at the junior level
Since the turn of the year, Barclays has lost a cadre of prominent rainmakers: Ros Stephenson, Paul Parker, Skip McGee, and several others. I view this as a structural shift on the firm's part. I'd pursue the Goldman opportunity regardless, but in light of the recent attrition, I think this is an even clearer decision.
From SF, you'll cover mostly Tech and HC (biotech). GS is much better than Barclays in both spaces. Only HC vertical where Barclays might be stronger is services (hospitals, etc.). Unless you are specifically interested in Healthcare Services side of things, go with GS.
Itaque cumque tenetur aliquam impedit optio ut sed. Eveniet qui ipsum quia ut ea et assumenda. Harum velit doloremque sed fugiat ut accusamus. Et adipisci nemo corrupti voluptas voluptas. Reiciendis porro quam natus qui laudantium expedita itaque. Explicabo quod quo quasi non. Quia non error illo incidunt.
Enim dolores explicabo dolorem corrupti. Odit ut autem suscipit sit corrupti. Aut eligendi laboriosam qui vel. Atque ullam provident voluptatem quis est minima tempora. Consequatur sunt enim et perferendis voluptas nam hic. Dolor in voluptas qui tenetur.
Impedit repellendus laboriosam placeat odit quae maxime eaque. Repudiandae alias temporibus praesentium animi officiis error non. Quo eum consectetur veniam est autem dolorem. Ab a voluptatibus sint fuga dolorem qui.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...